Drugs in Context 

Lead editorial – Atrial fibrillation and stroke risk

Professor Gregory Y H Lip
Professor of Cardiovascular Medicine, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

>> Abstract    >> Full text PDF

Disease overview – Stroke prevention in atrial fibrillation

Professor David Fitzmaurice
Primary Care Clinical Sciences, The University of Birmingham, Edgbaston, Birmingham, UK

>> Abstract    >> Full text PDF

Drug review – Dabigatran for stroke prevention in atrial fibrillation

Janet Marianne Jackson PhD
JUST Medical Media Limited, Auckland, New Zealand

>> Abstract    >> Full text PDF

Download the published issue
>> Full text PDF

Lead editorial – Major depressive disorder

Professor Stuart A Montgomery
Emeritus Professor of Psychiatry, Imperial College School of
Medicine, London

>> Abstract    >> Full text PDF

Specialist editorial – Major depressive disorder

Professor Anthony Hale
Professor of Psychiatry at the University of Kent

>> Abstract    >> Full text PDF

Disease overview – Major depressive disorder

R. Hamish McAllister-Williams PhD MD FRCPsych
Reader in Clinical Psychopharmacology and Honorary Consultant Psychiatrist, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK

>> Abstract    >> Full text PDF

Drug review – Valdoxan®  (agomelatine)

Janet Marianne Jackson PhD
JUST Medical Media Limited, Auckland, New Zealand

>> Abstract    >> Full text PDF

Improving practice – Major depressive disorder

Dr George Kassianos
General Practitioner, Berkshire, UK

>> Abstract    >> Full text PDF

Download the published issue
>> Full text PDF